You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Endocrine tumors

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Endocrine Neoplasms

Recruiting
  • Endocrine Tumors
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 26, 2023

    Endocrine Tumor Trial in Vandœuvre-lès-Nancy

    Recruiting
    • Endocrine Tumor
      • Vandœuvre-lès-Nancy, France
        CHU Nancy
      Mar 8, 2022

      Adrenal and Other Endocrine Tumors in Patients With Sudden Death

      Recruiting
      • Primary Aldosteronism
      • +3 more
      • Adrenal aldosterone synthase (CYP11B2) staining
      • +2 more
      • Helsinki, Finland
        Endocrinology, Helsinki University Hospital and University of He
      Jul 8, 2022

      Metastatic Colorectal Cancer, Metastatic Pancreatic Cancer, Metastatic Ovarian Cancer Trial run by the National Cancer Institute

      Recruiting
      • Metastatic Colorectal Cancer
      • +4 more
      • Young TIL
      • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 25, 2023

      Repository for Related Biological Studies

      Recruiting
      • Sarcoma
      • +4 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        Apr 7, 2022

        Adrenal Cortical Carcinoma, Medullary Thyroid Cancer, Thymic Neuroendocrine Carcinoma Trial in Shanghai (individualized mRNA

        Not yet recruiting
        • Adrenal Cortical Carcinoma
        • +3 more
        • individualized mRNA neoantigen vaccine (mRNA-0523-L001)
        • Shanghai, Shanghai, China
          Ruijin hospital, Shanghai Jiao-Tong University School of Medicin
        Nov 19, 2023

        Breast Cancer, Ovarian Cancer, Liposarcoma Trial (PF-07224826, Fulvestrant)

        Not yet recruiting
        • Breast Cancer
        • +5 more
        • (no location specified)
        Jun 7, 2023

        Multiple Endocrine Neoplasia Type 1, Pancreatic Neuroendocrine Tumor Trial in Nanning (EUS-guided fine-needle injection)

        Recruiting
        • Multiple Endocrine Neoplasia Type 1
        • Pancreatic Neuroendocrine Tumor
        • EUS-guided fine-needle injection
        • Nanning, Guangxi, China
          First Affiliated Hospital of Guangxi Medical University
        Sep 24, 2022

        Quality of Life and Tolerance of Patients Treated With

        Not yet recruiting
        • Metastatic Neuroendocrine Tumour
          • Lyon, France
            Hospices Civils de Lyon, Hopital Lyon Sud
          Sep 12, 2023

          Advanced Carcinoid Tumor, Digestive System Neuroendocrine Tumor, Multiple Endocrine Neoplasia Type 1 Trial in Houston

          Recruiting
          • Advanced Carcinoid Tumor
          • +4 more
          • Houston, Texas
            M D Anderson Cancer Center
          Sep 22, 2022

          Non-functional Neuroendocrine Tumors of Pancreatic Body and Tail

          Recruiting
          • Non Functioning Pancreatic Endocrine Tumor
          • Histopathological review, long-term prognosis and quality of life follow-up
          • Shanghai, Shanghai, China
            Department of Pancreatic Surgery, Fudan University Shanghai Canc
          Jun 8, 2023

          Primary Aldosteronism Due to Aldosterone Producing Adenoma, Primary Aldosteronism, Adrenal Tumors Trial in Singapore

          Recruiting
          • Primary Aldosteronism Due to Aldosterone Producing Adenoma
          • +2 more
          • 11C-Metomidate PET/CT imaging at Clinical Imaging Research Centre
          • Singapore, Singapore
          • +6 more
          Oct 26, 2023

          Neuroendocrine Tumors Trial in Montréal (68Ga-DOTATATE PET/CT)

          Enrolling by invitation
          • Neuroendocrine Tumors
          • 68Ga-DOTATATE PET/CT
          • Montréal, Quebec, Canada
            Jewish General Hospital
          Feb 8, 2021

          Neuroendocrine Tumor of Pancreas, Multiple Endocrine Neoplasia Type 1 Trial in Utrecht (High-dose-high precision MR-guided

          Recruiting
          • Neuroendocrine Tumor of Pancreas
          • Multiple Endocrine Neoplasia Type 1
          • High-dose-high precision MR-guided radiotherapy
          • Utrecht, Netherlands
            UMC Utrecht
          May 29, 2022

          Solid Tumor, Advanced Breast Cancer Trial in Milwaukee (Abemaciclib, Hydroxychloroquine 200 mg, Faslodex)

          Withdrawn
          • Solid Tumor
          • Advanced Breast Cancer
          • Milwaukee, Wisconsin
            Froedtert Hospital and the Medical College of Wisconsin
          Dec 21, 2022

          PIK3CA Mutation, Solid Tumor, Adult, HER2-negative Breast Cancer Trial (RLY-5836, Fulvestrant, Palbociclib)

          Not yet recruiting
          • PIK3CA Mutation
          • +7 more
          • (no location specified)
          Mar 7, 2023

          Breast Cancer, Solid Tumors Trial in Boston, Grand Rapids, Houston (PF-07220060 + PF-07104091 combination dose escalation,

          Recruiting
          • Breast Cancer
          • Solid Tumors
          • PF-07220060 + PF-07104091 combination dose escalation
          • +2 more
          • Grand Rapids, Michigan
          • +1 more
          Jun 28, 2022

          Gastro-enteropancreatic Neuroendocrine Tumor Trial (Pasireotide, Diazoxide)

          Withdrawn
          • Gastro-enteropancreatic Neuroendocrine Tumor
          • (no location specified)
          Feb 17, 2022

          Differentiated Thyroid Gland Carcinoma, Malignant Adrenal Gland Pheochromocytoma, Malignant Paraganglioma Trial in Houston

          Active, not recruiting
          • Differentiated Thyroid Gland Carcinoma
          • +3 more
          • Computed Tomography
          • +6 more
          • Houston, Texas
            M D Anderson Cancer Center
          Feb 17, 2022

          Tumors, Tumors, Glandular and Epithelial, Tumors by Histologic Type Trial in San Antonio (Entinostat, Placebo)

          Completed
          • Neoplasms
          • +14 more
          • San Antonio, Texas
            The START Center for Cancer Care
          Apr 21, 2022

          Neuroendocrine Tumor, Anaplastic Thyroid Cancer, Adenocarcinoma Trial in Spain (Cabozantinib 40 mg)

          Recruiting
          • Neuroendocrine Tumor
          • +4 more
          • Cabozantinib 40 mg
          • Badalona, Barcelona, Spain
          • +14 more
          Feb 15, 2022

          Breast Cancer, Solid Tumor Trial in Worldwide (Inavolisib, Fulvestrant, Letrozole)

          Recruiting
          • Breast Cancer
          • Solid Tumor
          • Boston, Massachusetts
          • +12 more
          Jan 10, 2023

          Advanced Solid Tumor, Breast Cancer Trial in Columbus, San Antonio, West Valley City (CFI-402257, Fulvestrant)

          Recruiting
          • Advanced Solid Tumor
          • Breast Cancer
          • Columbus, Ohio
          • +2 more
          Jul 26, 2022

          Neuroendocrine Tumors Trial in Uppsala (AdVince)

          Recruiting
          • Neuroendocrine Tumors
          • Uppsala, Sweden
            Endocrine Oncology Clinic, Uppsala University Hospital
          Nov 4, 2021

          Tumors, Tumors, Glandular and Epithelial, Tumors by Histologic Type Trial in San Antonio (Entinostat, Pembrolizumab)

          Completed
          • Neoplasms
          • +13 more
          • San Antonio, Texas
            The START Center for Cancer Care
          Jan 24, 2022